[HTML][HTML] Current Trends and Challenges of Microbiome Research in Bladder Cancer

I Isali, EK Helstrom, N Uzzo, A Lakshmanan… - Current Oncology …, 2024 - Springer
Microbiome research in bladder cancer presents significant challenges stemming from
technical and conceptual complexities. Addressing these challenges through standardization, …

[HTML][HTML] Decisional and prognostic impact of diagnostic ureteroscopy in high-risk upper tract urothelial carcinoma: A multi-institutional collaborative analysis …

…, M Finati, G Simone, G Tuderti, E Helstrom… - … Oncology: Seminars and …, 2024 - Elsevier
Background Diagnostic ureteroscopy (URS) with or without biopsy remains a subject of
contention in the management of upper tract urothelial carcinoma (UTUC), with varying …

The role of cytoreductive nephrectomy in the immuno-oncological therapy era

DE Magee, E Helstrom, A Kutikov - Current Opinion in Urology, 2023 - journals.lww.com
The role of cytoreductive nephrectomy in the immuno-oncologi... : Current Opinion in
Urology The role of cytoreductive nephrectomy in the immuno-oncological therapy era …

Targeting bladder cancer: A sex sensitive perspective in mutations and outcomes

I Isali, P Khooblall, E Helstrom, L Bukavina - Urologic Oncology: Seminars …, 2023 - Elsevier
The incidence of bladder cancer (BC) is more common in males, however, the clinical
outcome for females tends to be more unfavorable, as demonstrated by a 21% increase in …

[HTML][HTML] Population Estimates of Ovarian Cancer Risk in a Cohort of Patients with Bladder Cancer

L Bukavina, L Davis, E Helstrom, D Magee… - European Urology …, 2024 - Elsevier
Background and objective The rationale for oophorectomy during female cystectomy is not
adequately supported. The co-occurrence and timing of bladder cancer (BC) and ovarian …

EVALUATING THE EFFICACY OF INTRAVESICAL LACTOBACILLUS RHAMNOSUS GG AS A NOVEL THERAPEUTIC APPROACH IN BBN MURINE MODEL OF …

E Helstrom, H Valentine, R Chelluri, A Kutikov… - … Oncology: Seminars and …, 2024 - Elsevier
Introduction The current standard of care for high-risk non-muscle invasive bladder cancer (HR-NMIBC)
is Bacillus Calmette Guerin (BCG), however, it carries a non-responder rate of 30…

DECOMPRESSION OR NOT: THE ONGOING CHALLENGE OF MALIGNANT HYDRONEPHROSIS

D Magee, E Helstrom, S Bell, A Pandit, R Uzzo… - … Oncology: Seminars and …, 2024 - Elsevier
Introduction Malignant hydronephrosis occurs secondary to direct tumour invasion or
extrinsic compression by bulky tumours or lymphadenopathy. Despite this common referral to …

Association Between GLP1R Agonists and Prostate, Kidney, and Bladder Cancers

L Bukavina, E Helstrom, CJD Wallis… - European urology …, 2024 - pubmed.ncbi.nlm.nih.gov
… 1 , Emma Helstrom

Evidence of Gender Disparities in Citations and Altmetric Attention Score in Oncology

RA Campbell, E Helstrom, L Chew, R Eapen… - medRxiv, 2024 - medrxiv.org
In this study, we assess gender disparities in both citation rates and Altmetric Attention Scores
(AAS) within oncology, utilizing a dataset comprising over 600,000 articles from the past …

Social media network analysis of academic urologists' interaction within Twitter microblogging environment

SH Bell, C Sun, E Helstrom, JM Dubin, I Isali… - Société Internationale d' …, 2023 - siuj.org
… Bell,1 Clara Sun,2 Emma Helstrom,1 Justin M. Dubin,3 Ilaha Isali,4 Kirtishri Mishra,4
Andrew Gianakopoulos,2 Seyed Behzad Jazayeri,6 Mohit Sindhani,7 Lee Ponsky,4 …